Doctors may soon be able to use blood tests to predict how primary progressive multiple sclerosis (PPMS) will worsen overtime for patients.1 This opens the door to earlier interventions and personalized treatment plans, eventually creating opportunities to slow the progression of the disease. Primary progressive multiple sclerosis is a specific type of multiple sclerosis (MS) […]

The post A Sneak Peek Into Future Testing For Multiple Sclerosis appeared first on Medical News Bulletin.

At its 24th meeting in Geneva from 24 to 28 April 2023, the World Health Organization (WHO) Expert Committee made a landmark decision for patients with multiple sclerosis (MS). For the first time, it included treatments for Multiple Sclerosis in the Model Lists of Essential Medicines (EML). 1 What is the EML? The EML is […]

The post WHO Announces MS Drugs to be Added to Essential Medicines List appeared first on Medical News Bulletin.

Serological evidence points to human herpes virus subtype, HHV-6A, being a risk factor for multiple sclerosis. Multiple sclerosis is an autoimmune disease in which the individual’s own body attacks the protective coating around neurons in the central nervous system. Neurons are important for the transmission of information through the body and if the protective coating […]

The post Human herpes virus subtype found to be a potential risk factor for multiple sclerosis appeared first on Medical News Bulletin.

A recent study reports that utilizing Disease-Modifying Therapies (DMT) for MS, healthcare systems can reduce the utilization of resources in the long-term, despite the initially high cost. Multiple Sclerosis is one of the commonest neurological causes of long-term disability. The cause of the disease is unknown, but its symptoms typically involve the optic nerve, brainstem, […]

The post Disease-modifying Therapies for Multiple Sclerosis appeared first on Medical News Bulletin.

A new study has reported on the results of a tablet-based application for multiple sclerosis cognitive assessment, demonstrating equivalency in score and improved and faster administration procedure compared to paper-based assessments. Multiple Sclerosis (MS) is an autoimmune disease, in which the communication between neurons is disrupted due to the damage to myelin protein. Myelin covers […]

The post New Tablet-based Application for Multiple Sclerosis Cognitive Assessment appeared first on Medical News Bulletin.

Scientists investigate whether diet can help prevent fatigue in multiple sclerosis patients. Multiple sclerosis (MS) is an autoimmune disorder that affects the brain and spinal cord. The body’s immune system attacks the cells (oligodendrocytes) that make the fatty covers that surround nerve cells. This fatty cover is called the myelin sheath, this is why MS […]

The post Can diet help in management of fatigue in multiple sclerosis? appeared first on Medical News Bulletin.

Multiple Sclerosis (MS) is a chronic condition that affects the central nervous system. Over two million people are currently diagnosed with MS across the world, with the condition being three times more likely to occur in women than in men. Often people are diagnosed between the ages of 20-40, however, the condition can affect younger […]

The post What is Multiple Sclerosis? appeared first on Medical News Bulletin.

Understanding the mechanisms that cause multiple sclerosis may help guide the development of new treatment for progressive multiple sclerosis. Multiple sclerosis is an autoimmune disease of the central nervous system that involves inflammation-associated damage in the brain that leads to neurodegeneration. Patients with multiple sclerosis may have a relapsing-remitting form, where they cycle between periods […]

The post Towards a new treatment for progressive multiple sclerosis appeared first on Medical News Bulletin.